Partner Content Partner Content Social Listening for Pharma Companies Social Media in Pharma Conference
Events Partner Content The Return of 11th Annual Social Media in Pharma 2019 The Return of 11th Annual Social Media in Pharma 2019
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.